Cargando…
Interaction of Cannabis Use Disorder and Striatal Connectivity in Antipsychotic Treatment Response
Antipsychotic (AP) medications are the mainstay for the treatment of schizophrenia spectrum disorders (SSD), but their efficacy is unpredictable and widely variable. Substantial efforts have been made to identify prognostic biomarkers that can be used to guide optimal prescription strategies for ind...
Autores principales: | Blair Thies, Melanie, DeRosse, Pamela, Sarpal, Deepak K, Argyelan, Miklos, Fales, Christina L, Gallego, Juan A, Robinson, Delbert G, Lencz, Todd, Homan, Philipp, Malhotra, Anil K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418867/ https://www.ncbi.nlm.nih.gov/pubmed/32803161 http://dx.doi.org/10.1093/schizbullopen/sgaa014 |
Ejemplares similares
-
S20. PARAHIPPOCAMPAL THICKNESS PREDICTS TREATMENT IMPROVEMENT IN EARLY AND CHRONIC SCHIZOPHRENIA
por: Homan, Philipp, et al.
Publicado: (2018) -
Replication of a neuroimaging biomarker for striatal dysfunction in psychosis
por: Rubio, Jose M, et al.
Publicado: (2023) -
Replication of a neuroimaging biomarker for striatal dysfunction in psychosis
por: Rubio, Jose, et al.
Publicado: (2023) -
T23. ANTIPSYCHOTIC EXPOSURE AND STRIATAL FUNCTIONAL CONNECTIVITY IN PSYCHOSIS RELAPSE: A HYPOTHESIS GENERATING STUDY
por: Rubio, Jose, et al.
Publicado: (2020) -
Empirical Support for DSM-IV Schizoaffective Disorder: Clinical and Cognitive Validators from a Large Patient Sample
por: DeRosse, Pamela, et al.
Publicado: (2013)